LAVENTAIR

This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug LAVENTAIR contains a combination of these active pharmaceutical ingredients (APIs):

1 Vilanterol
UNII 028LZY775B - VILANTEROL

Vilanterol is a selective long-acting, beta2-adrenergic agonist (LABA). The pharmacologic effects of beta2-adrenoceptor agonist active substances, including vilanterol, are at least in part attributable to stimulation of intracellular adenylate cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

Read about Vilanterol
2 Umeclidinium
UNII 7AN603V4JV - UMECLIDINIUM BROMIDE

Umeclidinium is a long acting muscarinic receptor antagonist (also referred to as an anticholinergic). It is a quinuclidine derivative that is a muscarinic receptor antagonist with activity across multiple muscarinic cholinergic receptor subtypes. Umeclidinium bromide exerts its bronchodilatory activity by competitively inhibiting the binding of acetylcholine with muscarinic cholinergic receptors on airway smooth muscle.

Read about Umeclidinium

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LAVENTAIR Inhalation powder, pre-dispensed European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AL03 Vilanterol and umeclidinium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1649246, 1649257, 1649268
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 114899002
Country: FR Base de données publique des médicaments Identifier(s): 63989385
Country: IT Agenzia del Farmaco Identifier(s): 043444013, 043444025, 043444037
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1073418, 1073419, 1073420
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100315315

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.